We are KinetoChem
KinetoChem LLC is a US-based company which manufactures high purity synthetic cannabinoids for all stages of research. We offer Active Pharmaceutical Ingredients (APIs) for pre-clinical, clinical, and consumer goods with various quantities available (milligram, gram, and kilogram). Our facility and manufacturing processes meet all state and federal regulatory requirements including DEA Schedule I licensing for Analysis, Bulk Manufacturing, and Export.
KinetoChem has over 10 years’ experience manufacturing clinical and commercial (API) quantities of synthetic THC and CBD, as well as other minor cannabinoids. With our experience, we can help customers create the next cannabinoid finished drug product.
Everett McKinley
Founder & Chief Scientific Officer
Everett started his career in the lab at Radian Corporation (which eventually became Cerilliant) synthesizing a variety of compounds (drugs-of-abuse, drug metabolites, environmental reference materials, both native and isotope-labelled) on a wide range of scales (milligram up to multi-kilo).
After a couple of business development roles, he returned to the lab directing all Active Pharmaceutical Ingredient (API) manufacturing operations in two separate cGMP facilities. In this role, Everett co-authored a Drug Master File (DMF) for Cannabidiol (CBD) for a New Drug Application (NDA) submitted to the FDA. One of his favorite career projects was directing the design and construction of a new 53,000 sq. ft., award-winning cGMP pharmaceutical manufacturing facility.
At KinetoChem, Everett oversees all aspects of production: the synthesis, purification, and analytical development of all the cannabinoids produced.
Bryan Waltrip
Founder, COO & EVP Regulatory
Bryan has over 25 years of experience in pharmaceutical operations for both large pharma and small biotech start-up companies.
Bryan began his career with Allergan in QC & Validation in the Chemistry and Microbiology departments, creating new manufacturing finished product processes.
Bryan used this experience to successfully build new facilities and manufacturing processes to obtain FDA and DEA approval with multiple biotech and pharmaceutical companies for both drug substance and drug product.
At KinetoChem, Bryan manages business operations and oversees all state and federal regulatory guidelines for the manufacture of DEA and FDA regulated products.